Tsubota Laboratory Incorporated (4890) Stock Price & Analysis

4890 Stock Chart & Stats

¥243.00-¥3.00(-1.22%)

At close: Oct 30 3:30 PM GMT+9

Day’s Range: JPY 241.00 - JPY 248.00
52-Week Range: JPY 210.00 - JPY 478.00
Previous Close: JPY 246.00
Volume: 43.10K
Average Volume (3M): 30.84K
Market Cap: JPY 6.31B
Enterprise Value: JPY 5.27B
Total Cash (Recent Filing): JPY 699.26M
Total Debt (Recent Filing): JPY 63.64M
Price to Earnings (P/E): ―
Beta: 0.27
Next Earnings: Nov 11, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Low leverage and substantial equity provide a financial cushion while operations fluctuate. This structure can reduce solvency pressure, preserve borrowing capacity, and give management more flexibility to fund ophthalmology initiatives or absorb further earnings volatility.

Strong Gross Margin Potential

A gross margin near 66% indicates that the company’s offerings can retain meaningful value after direct costs. If revenue stabilizes, this margin profile could support operating leverage and improve profitability without requiring proportional increases in product volume.

Demonstrated Profitability Potential

Prior profitable periods, including the 2025 rebound, show that the business has previously converted its ophthalmology activities into operating and net earnings. This history supports the possibility of recovery if demand and revenue execution return to more normal levels.

Bears Say

Severe Revenue Contraction

The sharp 2026 revenue contraction materially weakens the company’s operating base and makes near-term recovery dependent on a substantial improvement in demand or commercialization. Such a decline can also reduce scale benefits and make fixed expenses harder to absorb.

Persistent Cash Burn

Persistent operating and free-cash-flow deficits indicate that the business is not currently self-funding its activities. Continued cash burn can increase reliance on external funding, reduce financial flexibility, and constrain investment in product development or commercialization.

Deep And Unstable Losses

The swing from positive earnings and returns to deeply negative profitability highlights substantial earnings instability. A net margin of -381% suggests that the current cost base is far too large for depressed revenue, creating material uncertainty around sustainable earnings power.

Tsubota Laboratory Incorporated News

Tsubota Laboratory Narrows Quarterly Loss as Revenue Surges and Eyes Full-Year Profit

Tsubota Laboratory Incorporated ( ($JP:4890) ) has issued an announcement. Tsubota Laboratory reported a sharp increase in first-quarter revenue to ¥215 million, up more than eightfold year on year, while

2M ago4890

Tsubota Lab Emphasizes ‘VISIONary INNOVATION’ in Vision and Brain Health

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Lab Co., an R&D-based venture from Keio University’s School of Medicine, concentrates on medical and healthcare innovations targeting visual

5M ago4890

Tsubota Laboratory Swings to Loss but Projects Sharp Rebound in 2027

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Laboratory reported a sharp downturn in non-consolidated results for the fiscal year ended March 31, 2026, with revenue plunging

5M ago4890

Tsubota Laboratory Swings to Heavy Loss as Revenue Plunges, Forecasts Deep Full-Year Deficit

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Laboratory reported a sharp deterioration in non-consolidated results for the nine months ended December 31, 2025, with revenue plunging

8M ago4890

Tsubota Laboratory’s Interim Financial Results Highlight Sustainable Growth Strategy

Tsubota Laboratory Incorporated ( ($JP:4890) ) has provided an announcement. Tsubota Laboratory Incorporated has announced its interim financial results for the fiscal year ending March 31, 2026, emphasizing its commitment

11M ago4890

Tsubota Laboratory Reports Significant Revenue Decline and Net Loss

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Laboratory Incorporated reported a significant decline in its financial performance for the six months ending September 30, 2025, with

11M ago4890

Tsubota Laboratory Reports First Quarter Losses Amidst Sales Decline

An update from Tsubota Laboratory Incorporated ( ($JP:4890) ) is now available. Tsubota Laboratory Incorporated reported a decrease in net sales and continuing losses for the first quarter of the

1y ago4890

Tsubota Laboratory Reports Strong Financial Recovery in FY2025

The latest announcement is out from Tsubota Laboratory Incorporated ( ($JP:4890) ). Tsubota Laboratory, Inc. reported significant financial improvement for the fiscal year ended March 31, 2025, with net sales

1y ago4890

Tsubota Laboratory’s Impressive Financial Turnaround in 2024

Tsubota Laboratory Incorporated (JP:4890) has released an update. Tsubota Laboratory, Inc. reports a significant increase in net sales and profitability for the first half of the fiscal year ending March

1y ago4890

4890 FAQ

What was Tsubota Laboratory Incorporated’s price range in the past 12 months?

Tsubota Laboratory Incorporated lowest stock price was ¥210.00 and its highest was ¥478.00 in the past 12 months.

What is Tsubota Laboratory Incorporated’s market cap?

Tsubota Laboratory Incorporated’s market cap is ¥6.31B.

When is Tsubota Laboratory Incorporated’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Tsubota Laboratory Incorporated’s earnings last quarter?

Tsubota Laboratory Incorporated released its earnings results on Aug 12, 2026. The company reported -¥5.2 earnings per share for the quarter.

Is Tsubota Laboratory Incorporated overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Tsubota Laboratory Incorporated pay dividends?

Tsubota Laboratory Incorporated does not currently pay dividends.

What is Tsubota Laboratory Incorporated’s EPS estimate?

Tsubota Laboratory Incorporated’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Tsubota Laboratory Incorporated have?

Tsubota Laboratory Incorporated has 25,969,738 shares outstanding.

What happened to Tsubota Laboratory Incorporated’s price movement after its last earnings report?

Tsubota Laboratory Incorporated reported an EPS of -¥5.2 in its last earnings report. Following the earnings report the stock price went up 2.23%.

Which hedge fund is a major shareholder of Tsubota Laboratory Incorporated?

Currently, no hedge funds are holding shares in JP:4890

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description